David Chiswell is Director of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 56,278 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

David Chiswell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
56,278 Reduced 100.0%
0 Common Stock
DC

David Chiswell

Director
Boston, MA

Track Institutional and Insider Activities on ALBO

Follow ALBIREO PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALBO shares.

Notify only if
Any

Insider Trading

Get notified when an Albireo Pharma, Inc. insider buys or sells ALBO shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to ALBIREO PHARMA, INC.

Track Activities on ALBO